DONG-A ST CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 60,500 KRW | +0.17% |
|
-0.49% | -12.45% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Dong-A ST Co Ltd is a Korea-based company mainly engaged in the production and sale of pharmaceuticals. The Company is involved of the manufacturing and sale of gastric mucosal protective agents, antihistamines, ischemic modifiers, antithrombotic agents, functional dyspepsia, hyperlipidemia, growth hormone, peptic ulcer treatments, cerebral metabolism improvement and hypertension treatments. It produces and sells diagnostic reagents for hepatitis E, I, A and B. In addition, it is engaged in the production and sale of medical devices including implants for artificial joint and maxillofacial surgery. The Company distributes its products in domestic and overseas markets such as Brazil, Turkey and Cambodia.
Sector
Pharmaceuticals
Calendar
2024-06-03
- Non Deal Roadshow
Trading Rating
Investor Rating
ESG Refinitiv
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -12.45% | 380M | |
| +16.20% | 78.51B | |
| +13.10% | 9B | |
| +42.06% | 4.96B | |
| -14.54% | 4.84B | |
| +9.01% | 3.72B | |
| +21.94% | 2.48B | |
| -27.22% | 2.19B | |
| +15.83% | 2.12B | |
| -39.50% | 1.94B |
- Stock Market
- Equities
- A170900 Stock
- News Dong-A ST Co., Ltd.
- Dong-A ST to Become Second-Largest Shareholder of Idience in KRW25 Billion Deal
